Glycomine
PrivateLast Round
Series C
Apr 16, 2025
Total Funding Raised
$228M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Glycomine is a biopharmaceutical company that develops orphan drugs aimed at treating rare metabolic disorders and protein misfolding through innovative replacement therapies and targeted intracellular delivery systems.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Glycomine Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Glycomine Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Apr 16, 2025 | ||||
| Series B | Jun 23, 2021 | ||||
| Series B | Aug 7, 2019 | ||||
| Series A | Nov 16, 2016 |
Glycomine Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Aberdeen Group plc | Series C |
| Asahi Kasei Therapeutics Venture Capital | Series B |
| Mesa Verde Venture Partners | Series A |
| CTI Life Sciences Fund | Series C |
| abrdn Inc. | Series C |
| Remiges Ventures | Series C, Series B |
| Advent Life Sciences | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors grew 63% MoM, from 1.3K to 2.2K.
- Apr 16, 2025
$115M round raised
Glycomine Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Glycomine's valuation, stock price, and market status.